
Funso Olufade discusses how solutions such as the new Adherence Package can help increase pharma–patient engagement.
Funs Olufade is Director Commercial Strategy â Daiichi Sankyo Europe, GmBH. Based in New Jersey, USA, Funso recently completed a 3 year European assignment where he led a cross-functional team through the development, regulatory submissions and commercial readiness for end of lifecycle management programs and generic defense strategy for the established products portfolio. He has worked primarily in the US but has lived in Switzerland & Germany.Contact details: funso.olufade@gmail.com or https://www.linkedin.com/in/funso-olufade-32343b8/
Published: August 31st 2017 | Updated: